-

$undefined

N/A

(N/A)

Theratechnologies Inc :THTX

Location: | Industry: | Sector:


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

107.2M

Cash

10.79M

Avg Qtr Burn

N/A

Short % of Float

0.14%

Insider Ownership

1.15%

Institutional Own.

50.11%

Qtr Updated

11/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

EGRIFTA SV® (tesamorelin for injection) Details
Human immunodeficiency virus, Abdominal Fat

PDUFA

Approval decision

Tesamorelin (F8 Formulation) Details
Human immunodeficiency virus, Abdominal Fat

PDUFA

Approval decision

Trogarzo® Intramuscular (IM) Details
Human immunodeficiency virus

BLA

Resubmission

Phase 1b

Update